Jun Nakamura, Takeshi Yamamoto, Yoshitsugu Takabatake, Tomoko Namba-Hamano, Atsushi Takahashi, Jun Matsuda, Satoshi Minami, Shinsuke Sakai, Hiroaki Yonishi, Shihomi Maeda, et al. Age-related TFEB downregulation in proximal tubules causes systemic metabolic disorders and occasional apolipoprotein A4-related amyloidosis. JCI insight. 2024
Maki SHINZAWA, Isao MATSUI, Yohei DOI, Ayumi MATSUMOTO, Atsushi TAKAHASHI, Masaomi NANGAKU, Yoshitaka ISAKA, Masami Ono, Yuriko Yonekura, Yuki Nishizawa, et al. A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan. Kidney International. 2024
Takayuki Kawaoka, Yusuke Sakaguchi, Tatsufumi Oka, Yuta Asahina, Koki Hattori, Yohei Doi, Nobuhiro Hashimoto, Yasuo Kusunoki, Satoko Yamamoto, Masafumi Yamato, et al. Seasonal variations in the association between proteinuria, CKD, and kidney failure. Nephrology Dialysis Transplantation. 2024
Satoshi Masuyama, Masayuki Mizui, Masashi Morita, Takatomo Shigeki, Hisakazu Kato, Takeshi Yamamoto, Yusuke Sakaguchi, Kazunori Inoue, Tomoko Namba-Hamano, Isao Matsui, et al. Enhanced fatty acid oxidation by selective activation of PPARα alleviates autoimmunity through metabolic transformation in T-cells. Clinical immunology (Orlando, Fla.). 2024. 268. 110357-110357
Sho Matsui, Takeshi Yamamoto, Yoshitsugu Takabatake, Atsushi Takahashi, Tomoko Namba-Hamano, Jun Matsuda, Satoshi Minami, Shinsuke Sakai, Hiroaki Yonishi, Jun Nakamura, et al. Empagliflozin protects the kidney by reducing toxic ALB (albumin) exposure and preventing autophagic stagnation in proximal tubules. Autophagy. 2024